REGISTERED
on 25 Jun 2024
Last Applicant/ Owned by
265 Watline Avenue
Mississauga, Ontario
CA
L4Z1P3
Serial Number
88004821 filed on 18th Jun 2018
Registration Number
7424197 registered on 25th Jun 2024
Correspondent Address
Richard M. LaBarge
Filing Basis
1. intent to use
Disclaimer
NO DATA
M MICROBIX
Providing diagnostic testing services, laboratory tests; production for others of cells, cell lines, viruses, bacteria, and pathogens, proteins, or nucleic acids in whole or in part; Research and development services in the field of process technology used in the manufacture of vaccines; process technology services to be used in the manufacture of a vaccine; biological cell-selection services for Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Licensing of process technology used in the manufacturing of vaccines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [044]
Medical, Beauty & Agricultural Services
Animal husbandry services; animal breeding services; sperm- and semen-sexing services in the nature of in vitro fertilization services; biological cell-selection services for medical purposes in the nature of in vitro fertilization services; medical services in the field of in vitro fertilization, namely, services of delivering energy to a population of biological cells for the purpose of selecting desired cells and negatively selecting undesired cells
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Providing diagnostic testing services, laboratory tests; production for others of cells, cell lines, viruses, bacteria, and pathogens, proteins, or nucleic acids in whole or in part; Research and development services in the field of process technology used in the manufacture of vaccines; process technology services to be used in the manufacture of a vaccine; biological cell-selection services for biological research purposes; biological research services of delivering energy to a population of biological cells for the purpose of selecting desired cells and negatively selecting undesired cells
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
automated flow cytometer sample introduction accessories used in conjunction with a flow cytometer to deliver biological and chemical samples from single test tubes and multiwell laboratory plates; medical apparatus for the automated analysis of cells in the nature of cytometers for medical diagnostic use; medical apparatus for the automated cytometric analysis of cells in the nature of cytometers for medical diagnostic use; medical apparatus in the nature of cytometers that detect atypia in cells for medical diagnostic use; medical apparatus for automated analysis of nuclear features for the detection of neoplasms and cancer and genetic conditions; apparatus for medical diagnostic uses in the nature of an automated flow cytometer sample introduction accessory, namely, a machine which is used in conjunction with a flow cytometer to deliver biological and chemical samples from single test tubes and multi-well laboratory plates
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
laboratory instruments for the detection pathogens and toxins in a biological sample for research use; Instruments for the processing of cells and cell derived materials, namely, flow cytometers and flow-based analyzers that detect and analyze nucleic acid content for scientific, laboratory, and general research use; laboratory instruments that detect pathogens in a biological sample for research use; Instruments for the processing of cells and cell derived materials
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
urokinase used to treat blood clots; Thrombolytic drugs, namely, plasminogen activating drugs and fibrinolytic drugs; urokinase preparations for the restoration of patency to central venous catheters obstructed by clotted blood or fibrin; urokinase preparations for treating pulmonary embolism; urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; urokinase preparations for treating thrombosis; urokinase preparations for treating coronary artery thrombosis; urokinase preparations for treating myocardial infarction; urokinase preparations for the lysis of thrombi; urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; urokinase preparations for treating deep vein thrombosis; urokinase preparations for treating pleural effusions; urokinase preparations for treating peripheral arterial occlusion; urokinase preparations for treating ischemic stroke; urokinase preparations for treating lower limb ischemia; test samples used in conjunction with laboratory diagnostics in the nature of biological or biochemical samples used to verify the reliability of laboratory equipment; test samples used in conjunction with assay methods in the nature of biological or biochemical assay samples used to verify the reliability of laboratory tests; Liquid, frozen and lyophilized inactivated, native pathogens, including whole and fragmented eukaryotes, prokaryotes, and viruses, independent and in host cells, all for in vitro and in vivo scientific or diagnostic use; inactivated, native pathogens, namely, liquid, frozen or lyophilized recombinant DNA and/or RNA preparations, either purified or within host organisms, in various buffers, singly and in combination, all for in vitro and in vivo scientific or diagnostic use; Positive controls, namely, reagents for use with nucleic-acid-based, immunologic, or other diagnostic tests to confirm proper test operation, and run in conjunction with patient samples run to confirm, assess, test, or verify the operation of the test method; proficiency test samples in the nature of biological test samples used to test the proficiency of technicians who use infectious disease diagnostics test systems to determine the pathogenic or biochemical content of samples; Diagnostic reagents in the nature of biotechnology products for medical and veterinary use, namely, micro-organisms for amplification controls; Diagnostic kits for in-vitro scientific and diagnostic use; Laboratory assay kits for scientific and diagnostic use; Biological material for scientific or diagnostic purposes, in the nature of serum and plasma from infected and disease state individuals used for verification and validation of human diagnostic assays for such infections and diseases; Biotechnology products for scientific or diagnostic purposes, namely, reagents and solutions in the nature of viruses, bacteria, fungi, parasites, and derivatives thereof used to research, develop, manufacture, and validate infectious disease diagnostic tests; biochemical products, namely, antibodies for scientific or research use; diagnostic reagents containing lyophilized microorganisms, and reagents containing lyophilized microorganisms all for in-vitro use and for use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific research use; diagnostic reagents for medical research use; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; diagnostic preparations for medical research use; diagnostic preparations for scientific research use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Biochemical agents for in vitro and in vivo scientific or diagnostic use, namely, viruses, bacteria, parasites, and purified and unpurified whole, fragmented, and fractionated pathogens and pathogenic organisms; Cells and cell culture derived products for in vitro or in vivo scientific or diagnostic use, namely, for production of organisms, proteins, nucleic acids, or cellular fractions used as reagents or antigens, test articles, or controls; antibodies and thrombolytics for in vitro scientific or research use; Biochemicals in the form of monoclonal antibodies for in vitro scientific use; Biochemicals in the form of monoclonal antibodies for research use; Active Pharmaceutical Ingredients to stimulate blood-clot dissolving processes; Microbial antigens and antisera for in vitro diagnostic use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88004821
Mark Type
No Service Mark
Attorney Docket Number
No 30752/62232
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 25th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 20th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Mar 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 22nd Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 20th Feb 2024 | EXAMINER'S AMENDMENT ENTERED |
| 20th Feb 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 20th Feb 2024 | EXAMINERS AMENDMENT E-MAILED |